The Effect of Amoxicillin Pre-Exposure on Treatment Outcomes and Antimicrobial Susceptibility in Patients with Urogenital Chlamydia trachomatis Infection

References

• Kiguen AX, Marramá M, Ruiz S, et al. Prevalence, risk factors and molecular characterization of Chlamydia trachomatis in pregnant women from Córdoba, Argentina: a prospective study. PLoS One. 2019;14(5):e0217245. doi:10.1371/journal.pone.0217245
   PubMed Web of Science ®Google Scholar
• World Health Organization. Report on global sexually transmitted infection surveillance 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/277258/9789241565691-eng.pdf?sequence=5&isAllowed=y. Accessed January 13, 2023.
   Google Scholar
• Yue X, Gong X, Li J, et al. Epidemiologic features of genital Chlamydia trachomatis I nfection at national sexually transmitted disease surveillance sites in China, 2015—2019. Chin J Dermatol. 2020:596–601. doi:10.35541/cjd.20200317
   Google Scholar
• Huai P, Li F, Li Z, et al. Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study. BMC Infect Dis. 2018;18(1):534. doi:10.1186/s12879-018-3432-y
   PubMedGoogle Scholar
• Haggerty CL, Gottlieb SL, Taylor BD, et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201 Suppl 2:S134–155. doi:10.1086/652395
   PubMed Web of Science ®Google Scholar
• Lee YS, Lee KS. Chlamydia and male lower urinary tract diseases. Korean J Urol. 2013;54(2):73–77. doi:10.4111/kju.2013.54.2.73
   PubMedGoogle Scholar
• O’Connell CM, Ferone ME. Chlamydia trachomatis Genital Infections. Microb Cell. 2016;3(9):390–403. doi:10.15698/mic2016.09.525
   PubMedGoogle Scholar
• Division for STD control and prevention of China CDC, Dermatology division of Chinese Medical Association, Venereal subspecialty committee of Chinese Dermatologist Association. The diagnosis and therapy guidelines for syphilis, gonorrhea, and urogenital Chlamydia trachomatis infection (2020). (in Chinese). Chin J Dermatol. 2020;53(3):168–179. doi:10.35541/cjd.20190808
   Google Scholar
• Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis. 2010;201(1):42–51. doi:10.1086/648734
   PubMed Web of Science ®Google Scholar
• Horner PJ. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex Transm Infect. 2012;88(3):154–156. doi:10.1136/sextrans-2011-050385
   PubMed Web of Science ®Google Scholar
• Handsfield HH. Questioning azithromycin for chlamydial infection. Sex Transm Dis. 2011;38(11):1028–1029. doi:10.1097/OLQ.0b013e318227a366
   PubMed Web of Science ®Google Scholar
• Phillips-Campbell R, Kintner J, Schoborg RV. Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection. Antimicrob Agents Chemother. 2014;58(3):1782–1784. doi:10.1128/AAC.02097-13
   PubMed Web of Science ®Google Scholar
• Pitt R, Alexander S, Ison C, et al. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections. J Antimicrob Chemother. 2018;73(3):680–686. doi:10.1093/jac/dkx454
   PubMed Web of Science ®Google Scholar
• de Barbeyrac B. Current aspects of Chlamydia trachomatis infection. Presse Med. 2013;42(4 Pt 1):440–445. doi:10.1016/j.lpm.2012.09.025
   PubMedGoogle Scholar
• Fohner AE, Sparreboom A, Altman RB, et al. PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics. 2017;27(4):164–167. doi:10.1097/FPC.0000000000000270
   PubMed Web of Science ®Google Scholar
• Shao L, You C, Cao J, et al. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection. Int J Infect Dis. 2020;96:121–127. doi:10.1016/j.ijid.2020.03.015
   PubMed Web of Science ®Google Scholar
• Griffin MO, Fricovsky E, Ceballos G, et al. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol. 2010;299(3):C539–548. doi:10.1152/ajpcell.00047.2010
   PubMed Web of Science ®Google Scholar
• Borel N, Leonard C, Slade J, et al. Chlamydial Antibiotic Resistance and Treatment Failure in Veterinary and Human Medicine. Curr Clin Microbiol Rep. 2016;3:10–18. doi:10.1007/s40588-016-0028-4
   PubMed Web of Science ®Google Scholar
• Suchland RJ, Sandoz KM, Jeffrey BM, et al. Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. Antimicrob Agents Chemother. 2009;53(11):4604–4611. doi:10.1128/AAC.00477-09
   PubMed Web of Science ®Google Scholar
• de Barbeyrac B, Dupon M, Rodriguez P, et al. A Tn1545-like transposon carries the tet(M) gene in tetracycline resistant strains of Bacteroides ureolyticus as well as Ureaplasma urealyticum but not Neisseria gonorrhoeae. J Antimicrob Chemother. 1996;37(2):223–232. doi:10.1093/jac/37.2.223
   PubMed Web of Science ®Google Scholar
• Dégrange S, Renaudin H, Charron A, et al. Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines. Antimicrob Agents Chemother. 2008;52(2):742–744. doi:10.1128/AAC.00960-07
   PubMed Web of Science ®Google Scholar
• Mardassi B, Aissani N, Moalla I, et al. Evidence for the predominance of a single tet(M) gene sequence type in tetracycline-resistant Ureaplasma parvum and Mycoplasma hominis isolates from Tunisian patients. J Med Microbiol. 2012;61(Pt 9):1254–1261. doi:10.1099/jmm.0.044016-0
   PubMed Web of Science ®Google Scholar
• Panzetta ME, Valdivia RH, Saka HA. Chlamydia Persistence: a Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo. Front Microbiol. 2018;9:3101. doi:10.3389/fmicb.2018.03101
   PubMed Web of Science ®Google Scholar
• Hocking JS, Kong FY, Timms P, et al. Treatment of rectal chlamydia infection may be more complicated than we originally thought. J Antimicrob Chemother. 2015;70(4):961–964. doi:10.1093/jac/dku493
   PubMed Web of Science ®Google Scholar
• Kintner J, Lajoie D, Hall J, et al. Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations. Front Cell Infect Microbiol. 2014;4:44. doi:10.3389/fcimb.2014.00044
   PubMed Web of Science ®Google Scholar
• Lewis ME, Belland RJ, AbdelRahman YM, et al. Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front Cell Infect Microbiol. 2014;4:71. doi:10.3389/fcimb.2014.00071
   PubMed Web of Science ®Google Scholar
• Ds Y, Gao Z, Mx A, et al. Investigation of Amoxicillin Use in Fever Clinic Patients: standardized Application of Antibiotics is Still Challenging. Infect Microbes Dis. 2022;4(1):41–43. doi:10.1097/IM9.0000000000000081
   Google Scholar
• Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1. doi:10.1093/jac/dkg301
   PubMed Web of Science ®Google Scholar
• Suchland RJ, Geisler WM, Stamm WE. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob Agents Chemother. 2003;47(2):636–642. doi:10.1128/AAC.47.2.636-642.2003
   PubMed Web of Science ®Google Scholar
• Sandoz KM, Rockey DD. Antibiotic resistance in Chlamydiae. Future Microbiol. 2010;5(9):1427–1442. doi:10.2217/fmb.10.96
   PubMed Web of Science ®Google Scholar
• Mestrovic T, Ljubin-Sternak S. Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs. Front Biosci. 2018;23(4):656–670. doi:10.2741/4611
   Google Scholar
• Qi ML, Guo YL, Wang QQ, et al. Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection. Chin Med J. 2017;130(23):2852–2856. doi:10.4103/0366-6999.219159
   PubMed Web of Science ®Google Scholar
• Dugan J, Rockey DD, Jones L, et al. Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob Agents Chemother. 2004;48(10):3989–3995. doi:10.1128/AAC.48.10.3989-3995.2004
   PubMed Web of Science ®Google Scholar
• Shao L, Guo Y, Jiang Y, et al. Sensitivity of the Standard Chlamydia trachomatis Culture Method Is Improved After One Additional In Vitro Passage. J Clin Lab Anal. 2016;30(5):697–701. doi:10.1002/jcla.21924
   PubMed Web of Science ®Google Scholar
• Scidmore MA. Cultivation and Laboratory Maintenance of Chlamydia trachomatis. Curr Protoc Microbiol. 2005. doi:10.1002/9780471729259.mc11a01s00
   PubMedGoogle Scholar
• Orhan G, Bayram A, Zer Y, et al. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005;43(1):140–143. doi:10.1128/JCM.43.1.140-143.2005
   PubMed Web of Science ®Google Scholar
• Biswas S, Raoult D, Rolain JM. A bioinformatic approach to understanding antibiotic resistance in intracellular bacteria through whole genome analysis. Int J Antimicrob Agents. 2008;32(3):207–220. doi:10.1016/j.ijantimicag.2008.03.017
   PubMed Web of Science ®Google Scholar
• Dean D, Rothschild J, Ruettger A, et al. Zoonotic Chlamydiaceae species associated with trachoma, Nepal. Emerg Infect Dis. 2013;19(12):1948–1955. doi:10.3201/eid1912.130656
   PubMed Web of Science ®Google Scholar
• De Puysseleyr K, De Puysseleyr L, Dhondt H, et al. Evaluation of the presence and zoonotic transmission of Chlamydia suis in a pig slaughterhouse. BMC Infect Dis. 2014;14:1–6. doi:10.1186/s12879-014-0560-x
   PubMed Web of Science ®Google Scholar
• De Puysseleyr L, De Puysseleyr K, Braeckman L, et al. Assessment of Chlamydia suis Infection in Pig Farmers. Transbound Emerg Dis. 2017;64(3):826–833. doi:10.1111/tbed.12446
   PubMed Web of Science ®Google Scholar
• O’Neill CE, Seth-Smith H, Van Der Pol B, et al. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology. 2013;159(Pt 4):748–756. doi:10.1099/mic.0.065391-0
   PubMedGoogle Scholar
• Joseph SJ, Marti H, Didelot X, et al. Tetracycline Selective Pressure and Homologous Recombination Shape the Evolution of Chlamydia suis: a Recently Identified Zoonotic Pathogen. Genome Biol Evol. 2016;8(8):2613–2623. doi:10.1093/gbe/evw182
   PubMed Web of Science ®Google Scholar
• Aitolo GL, Adeyemi OS, Afolabi BL, et al. Neisseria gonorrhoeae Antimicrobial Resistance: past to Present to Future. Curr Microbiol. 2021;78(3):867–878. doi:10.1007/s00284-021-02353-8
   PubMed Web of Science ®Google Scholar
• Nguyen P, Pham HV, Van DH, et al. Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection. BMC Infect Dis. 2022;22(1):607. doi:10.1186/s12879-022-07595-w
   PubMed Web of Science ®Google Scholar
• Ieven M, Van Looveren M, Sudigdoadi S, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, Indonesia. Sex Transm Dis. 2003;30(1):25–29. doi:10.1097/00007435-200301000-00006
   PubMed Web of Science ®Google Scholar
• Pitt R, Sadouki Z, Town K, et al. Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae. J Antimicrob Chemother. 2019;74(7):2115–2116. doi:10.1093/jac/dkz130
   PubMed Web of Science ®Google Scholar
• Morris DJ, Jones LC, Davies RL, et al. MYCO WELL D-ONE detection of Ureaplasma spp. and Mycoplasma hominis in sexual health patients in Wales. Eur J Clin Microbiol Infect Dis. 2020;39(12):2427–2440. doi:10.1007/s10096-020-03993-7
   PubMed Web of Science ®Google Scholar
• Chalker VJ, Sharratt MG, Rees CL, et al. Tetracycline Resistance Mediated by tet(M) Has Variable Integrative Conjugative Element Composition in Mycoplasma hominis Strains Isolated in the United Kingdom from 2005 to 2015. Antimicrob Agents Chemother. 2021;65(4). doi:10.1128/AAC.02513-20
   PubMed Web of Science ®Google Scholar
• Li M, Zhang X, Huang K, et al. Presence of Chlamydia trachomatis and Mycoplasma spp., but not Neisseria gonorrhoeae and Treponema pallidum, in women undergoing an infertility evaluation: high prevalence of tetracycline resistance gene tet(M). AMB Express. 2017;7(1):206. doi:10.1186/s13568-017-0510-2
   PubMedGoogle Scholar
• Xue Y, Zheng H, Mai Z, et al. An in vitro model of azithromycin-induced persistent Chlamydia trachomatis infection. FEMS Microbiol Lett. 2017;364(14). doi:10.1093/femsle/fnx145
   PubMed Web of Science ®Google Scholar
• Bhengraj AR, Srivastava P, Mittal A. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin. Int J Antimicrob Agents. 2011;38(2):178–179. doi:10.1016/j.ijantimicag.2011.03.015
   PubMed Web of Science ®Google Scholar
• Deguchi T, Hatazaki K, Ito S, et al. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis. J Infect Chemother. 2018;24(8):610–614. doi:10.1016/j.jiac.2018.03.007
   PubMed Web of Science ®Google Scholar
• Wyrick PB, Knight ST. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother. 2004;54(1):79–85. doi:10.1093/jac/dkh283
   PubMed Web of Science ®Google Scholar
• Reveneau N, Crane DD, Fischer E, et al. Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. Antimicrob Agents Chemother. 2005;49(5):1787–1793. doi:10.1128/AAC.49.5.1787-1793.2005
   PubMed Web of Science ®Google Scholar
• Augenbraun MH, McCormack WM. Urethritis. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier Saunders; 2015:1349–1357.
   Google Scholar
• Skilton RJ, Cutcliffen LT, Barlow D, et al. Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle. PLoS One. 2009;4(11):e7723. doi:10.1371/journal.pone.0007723
   PubMed Web of Science ®Google Scholar
• Bhengraj AR, Vardhan H, Srivastava P, et al. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. Chemotherapy. 2010;56(5):371–377. doi:10.1159/000314998
   PubMed Web of Science ®Google Scholar
• Wang M, Jiang Y, Shao L, et al. In vitro susceptibilities of urogenital Chlamydia trachomatis clinical isolates to azithromycin alone and in combination with other antimicrobial agents. (in Chinese). Zhonghua Wei Sheng Wu Xue He Mian Yi Xue Za Zhi. 2010;8:722–726. doi:10.3760/cma.j.issn.0254-5101.2010.08.008
   Google Scholar
• Wang M, Jiang Y, Shao L, et al. Interactions between moxifloxacin and other antimicrobial agents against Chlamydia trachomatis in vitro. (in Chinese). J Clin Dermatol. 2011;40(1):4. doi:10.3969/j.issn.1000-4963.2011.01.003
   Google Scholar
• Singh V, Bala M, Bhargava A, et al. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. PLoS One. 2018;13(3):e0193678. doi:10.1371/journal.pone.0193678
   PubMed Web of Science ®Google Scholar